{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:15:55Z","timestamp":1768320955559,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["P50 CA210964"],"award-info":[{"award-number":["P50 CA210964"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.humpath.2022.11.003","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T02:23:42Z","timestamp":1667960622000},"page":"79-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Alternative lengthening of telomeres in primary hepatic neoplasms"],"prefix":"10.1016","volume":"131","author":[{"given":"Saba","family":"Yasir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongming Eric","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Knudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darlene","family":"Knutson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Kloft-Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rondell P.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhanpat","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanford M.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Teh","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8334-7725","authenticated-orcid":false,"given":"Michael","family":"Torbenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.11.003_bib1","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1016\/j.celrep.2017.05.087","article-title":"Extensive proliferation of human cancer cells with ever-shorter telomeres","volume":"19","author":"Dagg","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.humpath.2022.11.003_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13102384","article-title":"ALT positivity in human cancers: prevalence and clinical insights","volume":"13","author":"MacKenzie","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2022.11.003_bib3","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.ajpath.2011.06.018","article-title":"Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes","volume":"179","author":"Heaphy","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2022.11.003_bib4","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1158\/1078-0432.CCR-16-1113","article-title":"Alternative lengthening of telomeres and loss of DAXX\/ATRX expression predicts metastatic disease and poor survival in patients with pancreatic neuroendocrine tumors","volume":"23","author":"Singhi","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2022.11.003_bib5","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/modpathol.2013.68","article-title":"Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features","volume":"26","author":"Wood","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.11.003_bib6","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1111\/liv.14975","article-title":"Clinicopathological and molecular characterization of chromophobe hepatocellular carcinoma","volume":"41","author":"Kang","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.humpath.2022.11.003_bib7","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.humpath.2015.05.019","article-title":"Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas","volume":"46","author":"Liau","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.11.003_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1126\/science.1207313","article-title":"Altered telomeres in tumors with ATRX and DAXX mutations","volume":"333","author":"Heaphy","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.humpath.2022.11.003_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.humpath.2022.07.015","article-title":"The diagnostic and prognostic utility of incorporating DAXX, ATRX, and alternative lengthening of telomeres to the evaluation of pancreatic neuroendocrine tumors","volume":"129","author":"Heaphy","year":"2022","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.11.003_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.gtc.2017.01.009","article-title":"Morphologic subtypes of hepatocellular carcinoma","volume":"46","author":"Torbenson","year":"2017","journal-title":"Gastroenterol Clin N Am"},{"key":"10.1016\/j.humpath.2022.11.003_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.humpath.2021.09.009","article-title":"Morphological heterogeneity in beta-catenin-mutated hepatocellular carcinomas: implications for tumor molecular classification","volume":"119","author":"Torbenson","year":"2022","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.11.003_bib12","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/PAS.0000000000001711","article-title":"Morphologic and molecular findings in myxoid hepatic adenomas","volume":"45","author":"Rowan","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.11.003_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/modpathol.2017.103","article-title":"Molecular testing for the clinical diagnosis of fibrolamellar carcinoma","volume":"31","author":"Graham","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.11.003_bib14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.humpath.2020.12.009","article-title":"Hepatocellular carcinoma: making sense of morphological heterogeneity, growth patterns, and subtypes","volume":"112","author":"Torbenson","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2022.11.003_bib15","series-title":"Digestive systems tumors","year":"2019"},{"key":"10.1016\/j.humpath.2022.11.003_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00428-020-02868-8","article-title":"Ki-67 \"hot spot\" digital analysis is useful in the distinction of hepatic adenomas and well-differentiated hepatocellular carcinomas","volume":"478","author":"Jones","year":"2021","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2022.11.003_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.path.2018.02.007","article-title":"Hepatic adenomas: classification, controversies, and consensus","volume":"11","author":"Torbenson","year":"2018","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.humpath.2022.11.003_bib18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/PAS.0000000000001228","article-title":"Angiosarcoma of the liver: clinicopathologic features and morphologic patterns","volume":"43","author":"Yasir","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.11.003_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/19491034.2019.1685246","article-title":"ALT control, delete: FANCM as an anti-cancer target in alternative lengthening of telomeres","volume":"10","author":"O'Rourke","year":"2019","journal-title":"Nucleus"},{"key":"10.1016\/j.humpath.2022.11.003_bib20","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/modpathol.2009.125","article-title":"The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression","volume":"22","author":"Subhawong","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.11.003_bib21","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/gutjnl-2020-322595","article-title":"Non-functional pancreatic neuroendocrine tumours: ATRX\/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX\/PDX1 expression and tumour size","volume":"71","author":"Hackeng","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.humpath.2022.11.003_bib22","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1038\/s41467-021-25430-9","article-title":"Genetic and epigenetic basis of hepatoblastoma diversity","volume":"12","author":"Nagae","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2022.11.003_bib23","doi-asserted-by":"crossref","first-page":"13076","DOI":"10.1073\/pnas.1716483114","article-title":"DNAJB1-PRKACA fusion kinase interacts with beta-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma","volume":"114","author":"Kastenhuber","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2022.11.003_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jmoldx.2020.11.003","article-title":"A pan-cancer study of somatic TERT promoter mutations and amplification in 30,773 tumors profiled by clinical genomic sequencing","volume":"23","author":"Gupta","year":"2021","journal-title":"J Mol Diagn"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772200260X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772200260X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:41:02Z","timestamp":1758645662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004681772200260X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":24,"alternative-id":["S004681772200260X"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.11.003","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alternative lengthening of telomeres in primary hepatic neoplasms","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}